prikaz prve stranice dokumenta Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
  Download
PDF 882.52 KB
Professional paper - Letter to the editor
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Leukemia Research, 119 (2022); 106905. https://doi.org/10.1016/j.leukres.2022.106905
Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljic, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, Rajko

Cite this document

Lucijanić, M., Krečak, I., Sorić, E., Sabljic, A., Galušić, D., Holik, H. ... Kušec, R. (2022). Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research, 119.. doi: 10.1016/j.leukres.2022.106905

Lucijanić, Marko, et al. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research, vol. 119, 2022. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Anica Sabljic, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović and Rajko Kušec. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research 119 (2022). https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, M., et al. (2022) 'Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis', Leukemia Research, 119. doi: 10.1016/j.leukres.2022.106905

Lucijanić M, Krečak I, Sorić E, Sabljic A, Galušić D, Holik H, and sur.. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research [Internet]. 2022 August [cited 2024 April 24];119. doi: 10.1016/j.leukres.2022.106905

M. Lucijanić, et al., "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis", Leukemia Research, vol. 119, August 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:524953. [Accessed: 24 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
AuthorMarko Lucijanić
AuthorIvan Krečak
AuthorEna Sorić
AuthorAnica Sabljic
AuthorDavor Galušić
AuthorHrvoje Holik
AuthorVlatka Periša
AuthorMartina Morić Perić
AuthorIvan Zekanović
AuthorRajko Kušec
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Keywords (english)
Languageenglish
Publication typeProfessional paper - Letter to the editor
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleLeukemia Research
Numberingvol. 119, 106905
p-ISSN0145-2126
DOIhttps://doi.org/10.1016/j.leukres.2022.106905
URN:NBNurn:nbn:hr:105:524953
Publication2022-08
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S014521262200131X
Type of resourceText
Access conditionsOpen access
Embargo expiration date: 2023-09-01
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-12-29 10:44:20